Eylea Injection Treatment of Macular Degeration - AMDF
https://www.macular.org/about-macular-degeneration/wet-macular-degeneration/treatments-for-wet-macular-degeneration/eylea-injection-treatment
WEBEylea (Eylea/VEGF Trap-Eye from Regeneron/Bayer) is one form of anti-VEGF therapy, and recently approved by the Food and Drug Administration. Other variants of anti-VEGF injections include ranibizumab (Lucentis, made by Genentech/Novartis), and bevacizumab (off label Avastin from Genentech).
DA: 77 PA: 12 MOZ Rank: 11